copycat wegovy - Search News

News

Novo Nordisk, Wegovy and copycat

Reuters on MSN · 4d

Wegovy maker Novo Nordisk warns on continued copycat-drug challenge as new CEO readied

Novo Nordisk cautioned on Wednesday that it expects continued competition this year from copycat versions of its Wegovy obesity drug, as it battled pressure from compounding pharmacies in the United States and rival Eli Lilly.

The Wall Street Journal on MSN · 3d

Novo Nordisk’s Wegovy Weight-Loss Drug Sales Surge Despite Copycat Issues

Second-quarter sales of the blockbuster drug soared 67% on year, despite millions of U.S. patients using generic unbranded versions of the drug.

The Globe and Mail · 4d

Wegovy maker Novo Nordisk warns continued copycat-drug competition as it loses U.S. market share

Competition from compounders had Novo cut its full-year sales and profit outlook, $95-billion wiped off company market value

4d

Ozempic maker goes to war with ‘fake’ copycat jabs as sales slow

The maker of Ozempic and Wegovy has declared war on “fake” copycat weight-loss jabs as it battles a sales slowdown.

3d

Cash pay is 'going to constitute a major part of the Wegovy business': Novo Nordisk CFO

Novo Nordisk CFO Karsten Munk Knudsen tells Yahoo Finance the company understands the pressure it is under to deliver better ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results